trending Market Intelligence /marketintelligence/en/news-insights/trending/2bg76qldfi-eiyod-busmq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Cord Blood America closes asset sale, changes name to CBA

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Cord Blood America closes asset sale, changes name to CBA

Cord Blood America Inc. closed the deal to sell its assets to privately held California Cryobank Stem Cell Services LLC, also known as FamilyCord.

FamilyCord now owns substantially all assets of Cord Blood America and its wholly owned subsidiaries, and assumed certain liabilities.

The deal was worth $15.5 million — FamilyCord paid $12.5 million at closing, and the remaining $3.0 million was deposited into escrow. Las Vegas-based Cord Blood said it plans to distribute a portion of the sale proceeds to its shareholders.

As part of the deal, upon closing, the company changed its name to CBA Inc.

Separately, CBA's board appointed Anthony Snow president and corporate secretary. Snow was appointed interim president in July 2017, following the resignation of Stephen Morgan as interim president, general counsel and corporate secretary.

California Cryobank Stem Cell Services is a unit of California Cryobank Inc., a sperm bank in Los Angeles.

Cord Blood provides umbilical cord blood and cord tissue stem cell processing and storage services.